Literature DB >> 2166969

Recurrence in juvenile angiofibroma.

A McCombe1, V J Lund, D J Howard.   

Abstract

A potential for recurrence of juvenile angiofibroma exists after all treatment modalities, both surgical and medical but the methods of defining recurrence and failure to cure varies considerably from series to series. To evaluate factors which might influence successful treatment, a series of 33 patients have been reviewed retrospectively. All patients were treated by simple or extended lateral rhinotomy as a primary or secondary procedure. The final long-term disease control rate was 97% but during the treatment period the overall symptomatic recurrence rate was 50%. However, amongst those treated primarily the recurrence rate was 34%. Of the factors examined, the strongest predictor of recurrence was preoperative embolisation. This group exhibited both early and multiple recurrence when compared with the non-embolised group and the possible reasons for this are examined.

Entities:  

Mesh:

Year:  1990        PMID: 2166969

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  13 in total

1.  A Drastic Aftermath of Embolisation in Juvenile Nasopharyngeal Angiofibroma.

Authors:  Narayanan Janakiram; Shilpee Bhatia Sharma; Vidya Bhargavan Panicker; C V Srinivas
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-07-09

2.  Complications of Midface Swing for Management of Juvenile Nasopharyngeal Angiofibroma.

Authors:  Sanjay Roy Chowdhury; K Rajkumar; Tushar Deshmukh
Journal:  J Maxillofac Oral Surg       Date:  2016-08-05

3.  Recurrent juvenile nasopharyngeal angiofibroma treated with gamma knife surgery.

Authors:  Chul-Kee Park; Dong Gyu Kim; Sun Ha Paek; Hyun-Tai Chung; Hee-Won Jung
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

4.  Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas.

Authors:  S C Abraham; E A Montgomery; F M Giardiello; T T Wu
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  [Navigated "targeted surgery" for skull base malignomas: additional space for surgical manipulation by neoadjuvant tumor downsizing].

Authors:  J Schipper; A Berlis; T Klenzner; A Schramm; N-C Gellrich; S Rosahl; W Maier
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

6.  Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.

Authors:  Silke Wemmert; Vivienne Willnecker; Philipp Kulas; Stefanie Weber; Cornelia Lerner; Sabrina Berndt; Olaf Wendler; Bernhard Schick
Journal:  Tumour Biol       Date:  2015-11-17

7.  Recurrence Rate after Endoscopic vs. Open Approaches for Juvenile Nasopharyngeal Angiofibroma: A Meta-analysis.

Authors:  Camilo Reyes; Heather Bentley; J Alejandro Gelves; C Arturo Solares; J Kenneth Byrd
Journal:  J Neurol Surg B Skull Base       Date:  2018-12-26

8.  Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing.

Authors:  Joel W Jones; Shireen Usman; Jacob New; Andrew Holcomb; Sumedha Gunewardena; Ossama Tawfik; Larry Hoover; Daniel Bruegger; Sufi Mary Thomas
Journal:  Otolaryngol Head Neck Surg       Date:  2018-04-10       Impact factor: 3.497

9.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

10.  Nasopharyngeal angiofibroma: Our experience and literature review.

Authors:  Mariane Barreto Brandão Martins; Francis Vinicius Fontes de Lima; Carlos Alberto Mendonça; Eduardo Passos Fiel de Jesus; Arlete Cristina Granizo Santos; Valéria Maria Prado Barreto; Ronaldo Carvalho Santos
Journal:  Int Arch Otorhinolaryngol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.